Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a

European Journal of Pharmacology

Volumn 643, Issue 2-3, 2010, Pages 153-161

  Gozé, Catherine ^a   Bergé, Gilbert ^a   M'Kadmi, Céline ^a   Floquet, Nicolas ^a   Gagne, Didier ^a   Galleyrand, Jean Claude ^a   Fehrentz, Jean Alain ^a   Martinez, Jean ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Basal constitutive activity; GHS R1a; Molecular modelling; Mutant receptor

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; INOSITOL PHOSPHATE; ISOLEUCINE; LEUCINE; METHIONINE; TRYPTOPHAN; VALINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HORMONE RECEPTOR INTERACTION; MUTANT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 77955274493     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.018     Document Type: Article

References (30)

1. Blaker M., Ren Y., Seshadri L., McBride E.W., Beinborn M., Kopin A.S. CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides. Mol. Pharmacol. 2000, 58:399-406.
2. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., Stevens R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
3. Chu K.M., Chow K.B., Leung P.K., Lau P.N., Chan C.B., Cheng C.H., Wise H. Over-expression of the truncated ghrelin receptor polypeptide attenuates the constitutive activation of phosphatidylinositol-specific phospholipase C by ghrelin receptors but has no effect on ghrelin-stimulated extracellular signal-regulated kinase 1/2 activity. Int. J. Biochem. Cell Biol. 2007, 39:752-764.
4. Colson A.O., Perlman J.H., Jinsi-Parimoo A., Nussenzveig D.R., Osman R., Gershengorn M.C. A hydrophobic cluster between transmembrane helices 5 and 6 constrains the thyrotropin-releasing hormone receptor in an inactive conformation. Mol. Pharmacol. 1998, 54:968-978.
5. Feighner S.D., Howard A.D., Prendergast K., Palyha O.C., Hreniuk D.L., Nargund R., Underwood D., Tata J.R., Dean D.C., Tan C.P., McKee K.K., Woods J.W., Patchett A.A., Smith R.G., Van der Ploeg L.H. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 1998, 12:137-145.
6. Gutkind, J.S., 2000. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000. 40, Re1.
7. Ho S., Hunt H., Horton R., Pullen J., Pease L. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77:51-59.
8. Holst B., Cygankiewicz A., Jensen T.H., Ankersen M., Schwartz T.W. High constitutive signaling of the ghrelin receptor: identification of a potent inverse agonist. Mol. Endocrinol. 2003, 17:2201-2210.
9. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 2004, 279:53806-53817.
10. Holst B., Lang M., Brandt E., Bach A., Howard A., Frimurer T.M., Beck-Sickinger A., Schwartz T.W. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Mol. Pharmacol. 2006, 70:936-946.
11. Holst B., Nygaard R., Valentin-Hansen L., Bach A., Engelstoft M.S., Petersen P.S., Frimurer T.M., Schwartz T.W. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors. J. Biol. Chem. 2010, 285:3973-3985.
12. Joubert L., Claeysen S., Sebben M., Bessis A.S., Clark R.D., Martin R.S., Bockaert J., Dumuis A. A 5-HT4 receptor transmembrane network implicated in the activity of inverse agonists but not agonists. J. Biol. Chem. 2002, 277:25502-25511.
13. Leff P. The two-state model of receptor activation. Trends Pharmacol. Sci. 1995, 16:89-97.
14. Leung P.K., Chow K.B., Lau P.N., Chu K.M., Chan C.B., Cheng C.H., Wise H. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell. Signal. 2007, 19:1011-1022.
15. Liu G., Fortin J.P., Beinborn M., Kopin A.S. Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. J. Pharmacol. Exp. Ther. 2007, 322:1036-1043.
16. Lu X., Huang W., Worthington S., Drabik P., Osman R., Gershengorn M.C. A model of inverse agonist action at thyrotropin-releasing hormone receptor type 1: role of a conserved tryptophan in helix 6. Mol. Pharmacol. 2004, 66:1192-1200.
17. Manivet P., Schneider B., Smith J.C., Choi D.S., Maroteaux L., Kellermann O., Launay J.M. The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis. J. Biol. Chem. 2002, 277:17170-17178.
18. Marie J., Richard E., Pruneau D., Paquet J.L., Siatka C., Larguier R., Ponce C., Vassault P., Groblewski T., Maigret B., Bonnafous J.C. Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure. J Biol Chem. 2001, 276:41100-41111.
19. McAllister S.D., Hurst D.P., Barnett-Norris J., Lynch D., Reggio P.H., Abood M.E. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation. J. Biol. Chem. 2004, 279:48024-48037.
20. Mousseaux D., Le Gallic L., Ryan J., Oiry C., Gagne D., Fehrentz J.A., Galleyrand J.C., Martinez J. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKC varepsilon pathway. Br. J. Pharmacol. 2006, 148:350-365.
21. Pantel J., Legendre M., Cabrol S., Hilal L., Hajaji Y., Morisset S., Nivot S., Vie-Luton M.P., Grouselle D., de Kerdanet M., Kadiri A., Epelbaum J., Le Bouc Y., Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest. 2006, 116:760-768.
22. Parnot C., Miserey-Lenkei S., Bardin S., Corvol P., Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 2002, 13:336-343.
23. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., Schertler G.F., Weis W.I., Kobilka B.K. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450:383-387.
24. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Yao X.J., Weis W.I., Stevens R.C., Kobilka B.K. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318:1266-1273.
25. Schwartz T.W., Frimurer T.M., Holst B., Rosenkilde M.M., Elling C.E. Molecular mechanism of 7TM receptor activation: a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 2006, 46:481-519.
26. Seifert R., Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol. 2002, 366:381-416.
27. Swaminath G., Deupi X., Lee T.W., Zhu W., Thian F.S., Kobilka T.S., Kobilka B. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J. Biol. Chem. 2005, 280:22165-22171.
28. Swaminath G., Xiang Y., Lee T.W., Steenhuis J., Parnot C., Kobilka B.K. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. J Biol Chem. 2004, 279:686-691.
29. Vichi P., Whelchel A., Posada J. Transmembrane helix 7 of the endothelin B receptor regulates downstream signaling. J. Biol. Chem. 1999, 274:10331-10338.
30. Wess J., Nanavati S., Vogel Z., Maggio R. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J. 1993, 12:331-338.